Glenmark Pharmaceuticals - Outcome of Operations Committee Meeting

Glenmark Pharmaceuticals Ltd has informed BSE that at the Operations Committee of the Board of Directors (CoD) at its meeting held on June 08, 2007, has approved conversion of Zero Coupon Foreign Currency Convertible Bonds amounting to US$ 4,000,000 into 3,44,988 Equity Shares at a price of Rs 506.22 per share of face value Rs 2/- each out of US$ 50,000,000 Zero Coupon Foreign Currency Convertible Bonds issued in 2005.